Founded in 2023, Worthmed is a product of Value for Health CoLAB (VOH.CoLAB), created by engineers and health innovation researchers.
It emerged from hands-on experience supporting innovators who struggled to translate technical progress into funding readiness, clinical validation, and market adoption. Worthmed provides the structure needed to move toward real-world impact.
Demonstrating TRL progression aligned with funding and regulatory expectations.
Designing validation pathways that generate credible evidence and enable pilots.
Defining buyer and payer pathways to support market entry and scale.